Home
Race Oncology Limited (ASX:RAC) - Hidden Gems Webinar Presentation
PUBLISHED
2020-12-07
Content
[embed]https://player.vimeo.com/video/487937781[/embed]
Presenter – Dr Daniel Tillett – Race Oncology is an ASX listed precision oncology company with a Phase II/III cancer drug called Bisantrene. Bisantrene is a potent inhibitor of the Fat mass and obesity-associated (FTO) protein.